Bradley S. Hargreaves
Net Worth
Last updated:
What is Bradley S. Hargreaves net worth?
The estimated net worth of Mr. Bradley S. Hargreaves is at least $586,070 as of 6 Apr 2022. He owns shares worth $158,678 as insider, has earned $197,292 from insider trading and has received compensation worth at least $230,100 in Cell MedX Corp..
What is the salary of Bradley S. Hargreaves?
Mr. Bradley S. Hargreaves salary is $46,020 per year as Vice President of Technology & Operations and Director in Cell MedX Corp..
How old is Bradley S. Hargreaves?
Mr. Bradley S. Hargreaves is 66 years old, born in 1959.
What stocks does Bradley S. Hargreaves currently own?
As insider, Mr. Bradley S. Hargreaves owns shares in one company:
Company | Title | Shares | Price per share | Total value |
---|---|---|---|---|
Cell MedX Corp. (CMXC) | Vice President of Technology & Operations and Director | 5,471,647 | $0.03 | $158,678 |
What does Cell MedX Corp. do?
Cell MedX Corp., a biotech company, focuses on the discovery, development, and commercialization of therapeutic and non-therapeutic products for patients with diabetes, Parkinson's disease, high blood pressure, neuropathy, and kidney functions. It develops and manufactures eBalance Pro System for professional use by healthcare practitioners in a clinical setting; and eBalance Home System for home use for general wellness and pain management treatment, which are controlled by the eBalance Console that acts as the central controller for three pre-programmed microcurrent algorithms, including wellness, pain management, and dual. The company was formerly known as Sports Asylum, Inc. and changed its name to Cell MedX Corp. in September 2014. Cell MedX Corp. was incorporated in 2010 and is based in Carson City, Nevada.
Bradley S. Hargreaves insider trading
Cell MedX Corp.
Mr. Bradley S. Hargreaves has made 37 insider trades between 2020-2022, according to the Form 4 filled with the SEC. Most recently he sold 10,000 units of CMXC stock worth $1,500 on 6 Apr 2022.
The largest trade he's ever made was exercising 1,234,855 units of CMXC stock on 13 Aug 2020. As of 6 Apr 2022 he still owns at least 5,471,647 units of CMXC stock.
Cell MedX Corp. key executives
Cell MedX Corp. executives and other stock owners filed with the SEC:
- Mr. Bradley S. Hargreaves (66) Vice President of Technology & Operations and Director
- Mr. Frank Edward McEnulty (69) Chief Executive Officer & Director
- Mr. Joao da Costa (61) Chief Operating Officer & Director
- Ms. Yanika Silina C.M.A., CPA (47) Chief Financial Officer, Treasurer, Corporation Sec. & Director